GEN Exclusives

More »

GEN News Highlights

More »
Jun 24, 2009

Kyoto Buys Fluidigm’s Technology to Research Stem Cell Reprogramming

  • Kyoto University’s Center for iPS Cell Research and Application (CiRA) purchased Fluidigm’s BioMark™ System to use in researching stem cell reprogramming.

    CiRA is using the microfluidic properties of BioMark’s integrated fluidic circuits to analyze selected genes in induced pluripotent stem (iPS) cells. The institute is also using the system to quantify copies of specific genes transferred into a cell to generate iPS cells.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »